Leukemia Clinical Trials in Philadelphia

Showing 1021-1040 of 1,744 trials

Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer

NCT00553800

This study will evaluate the combination of bevacizumab and erlotinib in elderly patients with advanced non-small cell lung cancer.

Carcinoma, Non-Small-Cell Lung

Fox Chase Cancer Center32 participantsStarted Jul 2007

Galloway, New Jersey, United States • Mount Holly, New Jersey, United States • Paoli, Pennsylvania, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children

NCT01955109

The objectives of this open-label follow-up study for subjects who previously were randomized and have completed the VIPES study for the treatment of peanut allergy, are: * To assess the efficacy of Viaskin Peanut after up to 36 months of treatment. * To evaluate the safety of long-term treatment with Viaskin Peanut. * To evaluate sustained unresponsiveness to peanut after a period of 2 months without treatment in subjects showing desensitization to peanut after treatment with Viaskin Peanut.

Peanut Allergy

DBV Technologies171 participantsStarted Sep 2013

San Diego, California, United States • Stanford, California, United States • Chicago, Illinois, United States +19 more locations

Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer

Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children

Leukemia Trials in Other Cities

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission

Intraoperative Imaging of Pulmonary Nodules by SGM-101

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

A Study of LY3023414 in Participants With Advanced Cancer

Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation

Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer

Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy

Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)

A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia

A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

Other Conditions in Philadelphia